Header

UZH-Logo

Maintenance Infos

Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?


Abstract

Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.

Abstract

Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.

Statistics

Citations

Dimensions.ai Metrics
4 citations in Web of Science®
4 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

77 downloads since deposited on 16 Jan 2018
64 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:22 August 2017
Deposited On:16 Jan 2018 07:09
Last Modified:24 Sep 2019 23:04
Publisher:American Society of Hematology
ISSN:2473-9529
OA Status:Hybrid
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1182/bloodadvances.2017006734
PubMed ID:29296789

Download

Download PDF  'Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?'.
Preview
Content: Published Version
Language: English
Filetype: PDF
Size: 1MB
View at publisher